GGrantIndex
← Leaderboards

Saraswathi Viswanathan

University Of Nebraska Medical Center

$2,460,414
Attributed
$3,189,217
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $615.8K · FY201325
$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,189,217 · 7
VA$0 · 1

By mechanism

R21$1,040,195 · 3
R01$748,162 · 1
P50$725,289 · 2
P20$675,571 · 1
I01$0 · 1

Top collaborators

Most similar at University Of Nebraska Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationLinkDietInflammatoryMediatingObesityMolecularProteinsAdipose TissueMetabolic DiseasesMetabolicAffectPlasmaTissuesFatty Acid Glycerol EstersLiverEnzymesFatty AcidsImpairmentFunctional DisorderFeedingMouse ModelChronicHigh Fat Diet

Grant awards (19)

Redox Signaling and AMPK Crosstalk on Alcohol-Induced Multi-Organ Damage: Liver and Adipose TIssue$374,081
R01 · FY2025 · AA · contact PI
The Role of TP-R on Alcohol-Induced Multi-Organ Damage: Liver and Heart$241,763
P50 · FY2025 · AA · contact PI
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2025 · VA · contact PI
Redox Signaling and AMPK Crosstalk on Alcohol-Induced Multi-Organ Damage: Liver and Adipose TIssue$374,081
R01 · FY2024 · AA · contact PI
The Role of TP-R on Alcohol-Induced Multi-Organ Damage: Liver and Heart$241,763
P50 · FY2024 · AA · contact PI
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2024 · VA · contact PI
The Role of TP-R on Alcohol-Induced Multi-Organ Damage: Liver and Heart$241,763
P50 · FY2023 · AA · contact PI
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2023 · VA · contact PI
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2022 · VA · contact PI
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2021 · VA · contact PI
Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy$169,392
R21 · FY2020 · CA · contact PI
The Role of TP-R on Adipose Tissue Browning: Therapeutic Implications in Alcoholic and Non-Alcoholic Fatty Liver Disease$152,996
R21 · FY2020 · AA · contact PI
Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy$202,561
R21 · FY2019 · CA · contact PI
The Role of TP-R on Adipose Tissue Browning: Therapeutic Implications in Alcoholic and Non-Alcoholic Fatty Liver Disease$184,496
R21 · FY2019 · AA · contact PI
The Effectiveness of NanoSOD in Ameliorating Ethanol-induced Liver Injury in Obesity$149,625
R21 · FY2018 · AA · contact PI
The Effectiveness of NanoSOD in Ameliorating Ethanol-induced Liver Injury in Obesity$181,125
R21 · FY2017 · AA · contact PI
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi$225,356
P20 · FY2015 · GM · contact PI
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi$225,750
P20 · FY2014 · GM · contact PI
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi$224,465
P20 · FY2013 · GM · contact PI